Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial-Reference-Cited by-同舟云学术

Severe nonalcoholic steatohepatitis and type 2 diabetes: liver histology after weight loss therapy in a randomized clinical trial

Published:2018-11-28 Issue:1 Volume:35 Page:157-165
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Oshakbayev Kuat¹^ORCID,Bimbetov Bakytzhan²^ORCID,Manekenova Kenzhegul³^ORCID,Bedelbayeva Gulnara⁴^ORCID,Mustafin Khalit⁵,Dukenbayeva Bibazhar⁶

Affiliation:

1. Metabolic Syndrome Department, Nazarbayev University Medical Center, “ANADETO” medical center, Astana, Kazakhstan;

2. Gastroenterology and Hepatology Department, Nazarbayev University Medical Center, Astana, Kazakhstan;

3. Faculty of Pathology, Medical University Astana, Kazakhstan;

4. Faculty of Postgraduate Education, Kazakh National Medical University named Asfendiarov, Almaty, Kazakhstan;

5. Department of Surgery, National Center for Neurosurgery, Astana, Kazakhstan;

6. Faculty of Pathology and Forensic Medicine, Medical University Astana, “ANADETO” medical center, Astana, Kazakhstan

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2018.1547696

Reference30 articles.

1. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

2. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

3. National Institute for Health and Care Excellence (NICE) guideline. Cirrhosis in over 16s: assessment and management. Methods, evidence and recommendations. July 2016. Available at: https://www.nice.org.uk/guidance/ng50

4. Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes

5. Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weight loss treatment for COVID-19 in patients with NCDs: a pilot prospective clinical trial;Scientific Reports;2024-05-14

2. Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention;Hepatology Communications;2023-09-27

3. Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes;Endocrine;2023-07-01

4. Weight loss treatment of COVID-19 in patients with NCDs: a pilot prospective clinical trial;2023-04-07

5. Principles of Nutritional Management in Patients with Liver Dysfunction—A Narrative Review;Livers;2023-04-04